PANTHERx® Rare Selected by Rhythm Pharmaceuticals Inc. as the Exclusive U.S. Specialty Pharmacy for the Expanded Indication for IMCIVREE® (setmelanotide)
Go back to PANTHERx® Rare Selected by Rhythm Pharmaceuticals Inc. as the Exclusive U.S. Specialty Pharmacy for the Expanded Indication for IMCIVREE® (setmelanotide)| (NASDAQ: RYTM) | Delayed: 108.26 +0.71 (0.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $107.55 | 52 Week High | $ | |||
| Open | $107.19 | 52 Week Low | $ | |||
| Day High | $111.71 | P/E | N/A | |||
| Day Low | $106.02 | EPS | $ | |||
| Volume | 690,636 | |||||
